Evidence map›Paper›PMID 22616867›Full record

ReviewBiochemical Society transactions2012

Engineering oxidoreductases: maquette proteins designed from scratch.

Bruce R Lichtenstein, Tammer A Farid, Goutham Kodali, Lee A Solomon, J L Ross Anderson, Molly M Sheehan, Nathan M Ennist, Bryan A Fry, Sarah E Chobot, Chris Bialas and 9 more

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An expandable, modular de novo protein platform for precision redox engineering.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
  7. Catalysis and Electron Transfer inChemical reviews · 2022
    Review
  8. Article
  9. Review
  10. Hydrogen bonding rearrangement by a mitochondrial disease mutation in cytochromeProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Review
  12. Quarterly reviews of biophysics · 2020
    Review
  13. Article
  14. Review
  15. The ascent of man(made oxidoreductases).Current opinion in structural biology · 2018
    Review
  16. Review
  17. Article
  18. Probing the quality control mechanism of theThe Journal of biological chemistry · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Bruce R LichtensteinJohnson Research Foundation, Department of Biochemistry and Biophysics, University of Pennsylvania, 422 Curie Boulevard, Philadelphia, PA 19104, U.S.A. lichtenstein@gmail.com
Tammer A Farid
Goutham Kodali
Lee A Solomon
J L Ross Anderson
Molly M Sheehan
Nathan M Ennist
Bryan A Fry
Sarah E Chobot
Chris Bialas
Joshua A Mancini
Craig T Armstrong
Zhenyu Zhao
Tatiana V Esipova
David Snell
Sergei A Vinogradov
Bohdana M Discher
Christopher C Moser
P Leslie Dutton
Johnson Foundation · USUniversity of Bristol · GBCornell University · USUniversity of Chicago · US

Funding

Natural Engineering of Multi-Electron Biological Oxidation & ReductionR01GM041048 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DUTTON, PETER LESLIE · 1989 to 2014
$5.0M
NIGMS NIH HHS R01 GM041048NIGMS NIH HHS R01 GM41048
6 · The paper itself

Abstract

The study of natural enzymes is complicated by the fact that only the most recent evolutionary progression can be observed. In particular, natural oxidoreductases stand out as profoundly complex proteins in which the molecular roots of function, structure and biological integration are collectively intertwined and individually obscured. In the present paper, we describe our experimental approach that removes many of these often bewildering complexities to identify in simple terms the necessary and sufficient requirements for oxidoreductase function. Ours is a synthetic biology approach that focuses on from-scratch construction of protein maquettes designed principally to promote or suppress biologically relevant oxidations and reductions. The approach avoids mimicry and divorces the commonly made and almost certainly false ascription of atomistically detailed functionally unique roles to a particular protein primary sequence, to gain a new freedom to explore protein-based enzyme function. Maquette design and construction methods make use of iterative steps, retraceable when necessary, to successfully develop a protein family of sturdy and versatile single-chain three- and four-α-helical structural platforms readily expressible in bacteria. Internally, they prove malleable enough to incorporate in prescribed positions most natural redox cofactors and many more simplified synthetic analogues. External polarity, charge-patterning and chemical linkers direct maquettes to functional assembly in membranes, on nanostructured titania, and to organize on selected planar surfaces and materials. These protein maquettes engage in light harvesting and energy transfer, in photochemical charge separation and electron transfer, in stable dioxygen binding and in simple oxidative chemistry that is the basis of multi-electron oxidative and reductive catalysis.

Indexed as

Oxidation-ReductionOxidoreductasesProtein EngineeringRecombinant ProteinsSynthetic BiologyOxidoreductasesRecombinant Proteins

Identifiers

PMID22616867
PMCPMC3525474
OpenAlexW2054687056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.